Research director, Dr. Alan Louie, is charged with spearheading Health Industry Insights' research service on the emerging opportunity for personalized health. In addition, he leads the company's research efforts focusing on technology and information technology (IT) innovations in drug discovery.
Dr. Louie brings more than 22 years of technical, product development, and business consulting experience from the diagnostics and biotechnology industries, including specific expertise in technology due diligence, in vitro diagnostic technology and product development, integrated device product development, automated biological sample handling, and consumer product development and commercialization projects.
Previously, Dr. Louie led applied biotechnology programs as Senior Manager at Arthur D. Little, Inc./TIAX LLC. In this role, he managed a number of laboratory-based technology development programs, as well as provided content expertise to healthcare management consulting projects. Prior to joining Arthur D. Little, he was responsible for the development and commercialization of more than 30 products for a variety of industries, including many first-in-class product offerings.
A recognized thought leader in both the health and life sciences industries, Dr. Louie is a frequently sought-after speaker at top industry events, including DIA and Drug Discovery Technology World Congress. He is also a highly regarded resource for the news media, with quotes in such renown publications as the Boston Business Journal, The Boston Globe, Drug Discovery News, The Scientist, and The Wall Street Journal. He is a current member of the American Association for the Advancement of Science, the Massachusetts Biotechnology Council, and DIA.
Dr. Louie graduated with a Ph.D. in Biochemistry from the University of California at Riverside and holds a B.A. in Biochemistry from the University of California at Berkeley.
